Cargando…
Response: Effects of Dapagliflozin on Endothelial Function, Renal Injury Markers, and Glycemic Control in Drug-Naïve Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2019:43:711–7)
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Diabetes Association
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943266/ https://www.ncbi.nlm.nih.gov/pubmed/31902150 http://dx.doi.org/10.4093/dmj.2019.0149 |
| _version_ | 1783484853178597376 |
|---|---|
| author | Kong, Sung Hye Koo, Bo Kyung Moon, Min Kyong |
| author_facet | Kong, Sung Hye Koo, Bo Kyung Moon, Min Kyong |
| author_sort | Kong, Sung Hye |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6943266 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Korean Diabetes Association |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-69432662020-01-09 Response: Effects of Dapagliflozin on Endothelial Function, Renal Injury Markers, and Glycemic Control in Drug-Naïve Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2019:43:711–7) Kong, Sung Hye Koo, Bo Kyung Moon, Min Kyong Diabetes Metab J Response Korean Diabetes Association 2019-12 2019-12-26 /pmc/articles/PMC6943266/ /pubmed/31902150 http://dx.doi.org/10.4093/dmj.2019.0149 Text en Copyright © 2019 Korean Diabetes Association http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Response Kong, Sung Hye Koo, Bo Kyung Moon, Min Kyong Response: Effects of Dapagliflozin on Endothelial Function, Renal Injury Markers, and Glycemic Control in Drug-Naïve Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2019:43:711–7) |
| title | Response: Effects of Dapagliflozin on Endothelial Function, Renal Injury Markers, and Glycemic Control in Drug-Naïve Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2019:43:711–7) |
| title_full | Response: Effects of Dapagliflozin on Endothelial Function, Renal Injury Markers, and Glycemic Control in Drug-Naïve Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2019:43:711–7) |
| title_fullStr | Response: Effects of Dapagliflozin on Endothelial Function, Renal Injury Markers, and Glycemic Control in Drug-Naïve Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2019:43:711–7) |
| title_full_unstemmed | Response: Effects of Dapagliflozin on Endothelial Function, Renal Injury Markers, and Glycemic Control in Drug-Naïve Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2019:43:711–7) |
| title_short | Response: Effects of Dapagliflozin on Endothelial Function, Renal Injury Markers, and Glycemic Control in Drug-Naïve Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2019:43:711–7) |
| title_sort | response: effects of dapagliflozin on endothelial function, renal injury markers, and glycemic control in drug-naïve patients with type 2 diabetes mellitus (diabetes metab j 2019:43:711–7) |
| topic | Response |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943266/ https://www.ncbi.nlm.nih.gov/pubmed/31902150 http://dx.doi.org/10.4093/dmj.2019.0149 |
| work_keys_str_mv | AT kongsunghye responseeffectsofdapagliflozinonendothelialfunctionrenalinjurymarkersandglycemiccontrolindrugnaivepatientswithtype2diabetesmellitusdiabetesmetabj2019437117 AT koobokyung responseeffectsofdapagliflozinonendothelialfunctionrenalinjurymarkersandglycemiccontrolindrugnaivepatientswithtype2diabetesmellitusdiabetesmetabj2019437117 AT moonminkyong responseeffectsofdapagliflozinonendothelialfunctionrenalinjurymarkersandglycemiccontrolindrugnaivepatientswithtype2diabetesmellitusdiabetesmetabj2019437117 |